Lily has over 25 years of experience in life sciences, including 15 years in strategy consulting.  Her primary areas of focus are portfolio and product strategy, new product planning, and launch readiness in oncology and rare diseases.  Prior to consulting, she worked at GSK and Patheon in pharmaceutical product development.  She has a BSc in biochemistry from the University of Waterloo, and an MBA from York University.